---
schema_version: "secwatch.filing_event.v1"
accession: "0000899923-24-000005"
form_type: "8-K"
ticker: "MYGN"
cik: "0000899923"
company_name: "MYRIAD GENETICS INC"
filed_at: "2024-01-16T23:59:59+00:00"
generated_at: "2026-06-06T23:44:09.780192+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Myriad Genetics prelim Q4 revenue $196-197M; GAAP EPS loss ($0.35)-($0.36); adjusted EPS $0.02-0.03

## Summary
- Preliminary Q4 2023 revenue $196-197M; GAAP diluted EPS loss ($0.35)-($0.36); adjusted EPS $0.02-$0.03.
- FY2023 revenue growth reaffirmed at least 10% YoY; prenatal volume growth at least 10% in Q4.
- Reaffirmed positive adjusted operating cash flow in Q4 2023; guided estimated cash and credit at year-end.
- Excluded items for non-GAAP: stock-based comp ~$10.3M, amortization ~$10.7M, transformation costs ~$14.1M, legal ~$0.6M, tax ~$2.0M.
- Reaffirmed FY2023 revenue and non-GAAP guidance originally provided on Nov 6, 2023.

## SEC filing metadata
- accession: 0000899923-24-000005
- form_type: 8-K
- ticker: MYGN
- cik: 0000899923
- company_name: MYRIAD GENETICS INC
- filed_at: 2024-01-16T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/899923/000089992324000005/0000899923-24-000005-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/899923/000089992324000005/mygn-20240110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000899923-24-000005
- JSON: https://secwatch.observer/filing/0000899923-24-000005.json
- Plain text: https://secwatch.observer/filing/0000899923-24-000005.txt

## Key facts
- Earnings Releases
  MYRIAD GENETICS INC reported fourth quarter 2023 results: revenue between approximately $196 and $197 million, EPS diluted GAAP earnings per share of between ($0.35) an d ($0.36), adj usted earnings per share of between $0.02 and $0.03. Guidance reaffirmed.
  - Period: fourth quarter 2023
  - Revenue: between approximately $196 and $197 million
  - EPS: diluted GAAP earnings per share of between ($0.35) an d ($0.36), adj usted earnings per share of between $0.02 and $0.03
  - Guidance: reaffirmed
  - Result: preliminary results
  source text: The Company also disclosed preliminary financial data for the fourth quarter of 2023, specifically that the Company expects fourth quarter 2023 revenue of between approximately $196 and $197 million, diluted GAAP earnings per share of between ($0.35) an d ($0.36), adj usted earnings per share of between $0.02 and $0.03, and GAAP and adjusted gross margin of approximately 70%.
  evidence_url: https://www.sec.gov/Archives/edgar/data/899923/000089992324000005/0000899923-24-000005-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.